
About Tivan Sciences
Tivan Sciences is a Healthcare company based in India founded in 2021. It manufactures pharmaceutical intermediates and APIs, focusing on quality and sustainability. It operates on a B2B model. Tivan Sciences offers products and services including Itopride HCL, Doxofylline, Rosuvastatin Calcium, Deferasirox, and Pitofenone HCL. Its focus areas include Pharmaceuticals, Therapeutics, Drug Development and API Manufacturing. Its legal entity in India is Tivan Sciences Private Limited (U24239GJ2020PTC112358). Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Tivan Sciences , Based In Rajkot, Gujarat, India, Specializes In Developing And Manufacturing High-quality Pharmaceutical Intermediates And Apis. They Adhere To Best Practices For Production, Ensuring Consistent Quality And Environmental Sustainability. Their Activities Include Creating Products For Therapeutic Categories Like Gastro Prokinetics And Bronchodilators, Serving The Pharmaceutical Industry Through Reliable Supply Chains.
- Headquarters India
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website tivansciences.com
- Social LinkedIn
- Legal Name Tivan Sciences Private Limited
- Date of Incorporation 28 Jan, 2020
- Jurisdiction Rajkot, Gujarat, India
- Annual Revenue₹48,354
FY 2023 · +4676% YoY
- Net Loss-₹7 Lakh
FY 2023 · -1439% margin
- EBITDA-₹6.3 Lakh
FY 2023 · -1306% margin
Associated legal entities of Tivan Sciences
Tivan Sciences operates through Tivan Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Tivan Sciences Private Limited CIN U24239GJ2020PTC112358 | Active | 28 Jan 2020 | Rajkot, Gujarat | ₹0.0 Cr | 18 | 4 | View details |
Products & Services of Tivan Sciences
Tivan Sciences offers a comprehensive portfolio of products and services, including Itopride HCL, Doxofylline, Rosuvastatin Calcium, Deferasirox, and Pitofenone HCL.
Treats gastrointestinal disorders as a prokinetic agent.
Manages asthma and COPD symptoms effectively.
Lowers cholesterol levels to prevent cardiovascular issues.
Removes excess iron from the body in chelation therapy.
Relieves muscle spasms and associated pain.
Treats attention deficit hyperactivity disorder symptoms.
Protects against oxidative stress in neurological conditions.
Chelates iron to treat overload conditions safely.
Controls spasms and related gastrointestinal issues.
Board of directors of Tivan Sciences Private Limited (Tivan Sciences)
Tivan Sciences Private Limited is the primary company behind Tivan Sciences. The board of Tivan Sciences Private Limited currently have 4 directors; the longest-serving is Siddharth Patel, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Siddharth Patel DIN 05220716 | Director | 28 Jan 2020 | 6 yrs 9 mo | Tivan Sciences Private Limited |
| Maheshkumar Vaghjibhai Savaliya DIN 01453595 | Director | 28 Jan 2020 | 6 yrs 9 mo | Tivan Sciences Private Limited |
| Kantilal Gopalbhai Savalia DIN 00373866 | Director | 17 Jan 2022 | 4 yrs 10 mo | Tivan Sciences Private Limited |
| Rajendra Chavda DIN 10105431 | Director | 07 Apr 2023 | 3 yrs 7 mo | Tivan Sciences Private Limited |
Financials of Tivan Sciences
Figures of Tivan Sciences Private Limited, the primary company behind Tivan Sciences, for FY 2023. Revenue was ₹48,354 (+4676% year on year). Net loss was -₹7 Lakh (-1439% margin). EBITDA was -₹6.3 Lakh (-1306% margin).
- ₹48,354Revenue · FY 2023 · +4676% YoY
- -₹7 LakhNet loss · -1439% margin
- -₹6.3 LakhEBITDA · -1306% margin
- ₹5.00 CrPaid-up capital
- 18Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Tivan Sciences Private Limited are on its company page.
Detailed financial statements for Tivan Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Tivan Sciences
Tivan Sciences has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Tivan Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tivan Sciences
Tivan Sciences was founded in 2021.
Tivan Sciences is headquartered in India.
The primary company behind Tivan Sciences, Tivan Sciences Private Limited, reported revenue of βΉ48,354 for FY 2023, up 4676% year on year.
Tivan Sciences , Based In Rajkot, Gujarat, India, Specializes In Developing And Manufacturing High-quality Pharmaceutical Intermediates And Apis. They Adhere To Best Practices For Production, Ensuring Consistent Quality And Environmental Sustainability. Their Activities Include Creating Products For Therapeutic Categories Like Gastro Prokinetics And Bronchodilators, Serving The Pharmaceutical Industry Through Reliable Supply Chains.
Tivan Sciences's top competitors include Laurus Labs, Symbiotec and SeQuent.
Tivan Sciences offers Itopride HCL, Doxofylline, Rosuvastatin Calcium, Deferasirox, and 5 more products and services.
Tivan Sciences operates through Tivan Sciences Private Limited.
The legal entities of Tivan Sciences currently have 4 directors, including Siddharth Patel, Rajendra Chavda, Kantilal Gopalbhai Savalia and others.